| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.fabinolife.com | |
| Market Cap | 6.11 Cr. | |
| Enterprise Value(EV) | 6.60 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.05 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 566.03 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 41.74 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 19.59 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 1.49 | Calculated using Price: 29.11 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.21 Cr. | 2,100,000 Shares |
| FaceValue | 10 | |
| About Fabino Life Sciences Ltd. | ||
| The company is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness focused consumer products. The company's core business is marketing of pharmaceutical formulation & products in domestic market through own distribution network and sales force under own brand name, getting its ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc. | ||
| 1 Day |
|
|
| 1 Week |
|
-4.99% |
| 1 Month |
|
-26.43% |
| 3 Month |
|
+0.38% |
| 6 Month |
|
-0.14% |
| 1 Year |
|
-6.10% |
| 2 Year |
|
+6.44% |
| 5 Year |
|
|
| 10 Year |
|
| 5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0.02 | 10.8 | 3.05 | 1.74 | 0.26 | |
| Return on Capital Employed (%) | 9.44 | 12.36 | 2.92 | 2.48 | 0.58 | |
| Return on Assets (%) | 0 | 1.14 | 1.04 | 1.37 | 0.22 |
| Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 1 | 1 | 1 | 4 | 4 | 4 | |
| Non Curr. Liab. | 0 | 1 | 0 | 0 | 0 | 1 | |
| Curr. Liab. | 8 | 2 | 1 | 0 | 0 | 1 | |
| Minority Int. | |||||||
| Equity & Liab. | 9 | 4 | 2 | 5 | 5 | 5 | |
| Non Curr. Assets | 1 | 1 | 0 | 0 | 0 | 0 | |
| Curr. Assets | 8 | 3 | 2 | 4 | 5 | 5 | |
| Misc. Exp. not W/O | |||||||
| Total Assets | 9 | 4 | 2 | 5 | 5 | 5 |
| Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Net Sales | 3 | 8 | 3 | 4 | 3 | |
| Other Income | 0 | 0 | ||||
| Total Income | 3 | 8 | 3 | 4 | 3 | |
| Total Expenditure | -2 | -7 | -3 | -4 | -3 | |
| PBIDT | 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | |
| Taxation | 0 | 0 | 0 | |||
| Exceptional Items | ||||||
| PAT | 0 | 0 | 0 | 0 | ||
| Adjusted EPS | 5 | 0 | 0 | 0 |
| Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 2 | 0 | -2 | -1 | |
| Cash Fr. Inv. | 0 | 0 | 0 | 0 | ||
| Cash Fr. Finan. | 0 | -2 | 0 | 2 | 0 | |
| Net Change | 0 | 0 | 1 | 0 | ||
| Cash & Cash Eqvt | 0 | 0 | 0 | 1 | 0 |
|
Tue, 16 Apr 2024
Certificate As Per Regulation 40 (9) For The Year Ended March 31 2024 Compliance certificate as per Regulation 40(9) For the Year Ended March 31 2024. |
|
Mon, 15 Apr 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Period Ended March 31 2024. Compliance certificate Under Regulation 7(3) of SEBI (Listing obligation and Disclosure requirements) Regulations 2015 for the period ended March 31 2024 |
|
Tue, 09 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance certificate under Reg 74 (5) of SEBI (DP) Regulation 2018. |
| Fri, 19 Apr 2024 |
Opening at High
|
Opening at Low
|
Opening at High for 3 days
|
Closing Below Previous Low
|
Closing Below Previous Low for 3 days
|
